Replies to post #41730 on Relief Therapeutics Holding AG (RLFTF)

[PennyWorld]

tcm55, well, near the bottom of the sites page it does reference NeuroxRx as the responsible party.

Responsible Party: NeuroRx, Inc.
ClinicalTrials.gov Identifier: NCT04360096 History of Changes
Other Study ID Numbers: RLF-100_002

And is also references all 3 (ZYESAMI™, aviptadil, and RLF-100).

I just find it suspicious that they would cut scope by removing patients that are suffering moderate to mild. Rather the big cut (change) resulted in the study focusing on the same patients as the EUA did, with the only major difference being one trial is IV and the other is inhaler.

And with 8/15/21 being the scheduled 'primary'completion date, I wonder if the FDA was waiting for the UNblinding of the trial before making a decision on the EUA. It just makes me wonder. All speculation on my part.